Sp1284

THE IMPORTANCE OF LONG-TERM CLINICAL OUTCOMES IN BIO-NAIVE PATIENTS

Date
May 8, 2023

Society: DDW

This case based presentation will highlight the importance of long-term clinical outcomes in bio-naive patients across both Crohn's disease and ulcerative colitis. Sponsored by Janssen Biotech, Inc.

Presenter


Tracks

Related Products

Thumbnail for LONG-TERM SAFETY OF 3 YEARS OF OZANIMOD IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: AN INTERIM ANALYSIS OF THE TRUE NORTH OPEN-LABEL EXTENSION
LONG-TERM SAFETY OF 3 YEARS OF OZANIMOD IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: AN INTERIM ANALYSIS OF THE TRUE NORTH OPEN-LABEL EXTENSION
BACKGROUND AND AIMS: A treat-to-target (TTT) strategy of striving for symptomatic and endoscopic remission is recommended for the management of inflammatory bowel diseases (IBD). Yet, real-world uptake of TTT strategies has been modest…
Thumbnail for TOP 3-5 TIPS FOR SURVIVING THE FIRST YEARS IN CLINICAL PRACTICE
TOP 3-5 TIPS FOR SURVIVING THE FIRST YEARS IN CLINICAL PRACTICE
The purpose of this session is to provide early career and trainee gastroenterologist with tips and strategies for having successful first few years in clinical practice…